| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jun―30 |
Uncovering SARS-CoV-2 variant - specific dysregulation in COVID-19 breakthrough infection through salivary transcriptomics |
Sourabh Tyagi, Anu Singh, Nipanshi Tyagi, Rupesh Chaturvedi, Hemant Ritturaj Kushwaha |
| 2 |
[GO] |
2026―Jun―04 |
Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and gastrointestinal stromal tumor |
Yufen Chen, Qingle Zeng, Baojia Luo, Xianxiang Chen |
| 3 |
[GO] |
2026―Mai―06 |
SARS-CoV-2 Brain Tropism Drives Spike RBD-Mediated Oncogenesis in Primary Glioma Cells |
Abhimanyu Thakur, Amy Dunne Miller, Lifan Liang, Sourav Banerjee, Kui Zhang |
| 4 |
[GO] |
2026―Apr―17 |
Deciphering SARS-CoV-2 EG.5: Advanced Molecular Docking and In-Silico Insights into Structural and Genetic Variations of Spike Protein Subvariants |
Sazan Q. Maulud, Rezhna Kh. Ali, Fuad O. Abdullah, Sangar Ali Hassan, Karzan A. Omar, Rebaz Anwar Omer, et al. (+2) Rebaz J. Qadr, Matteo Micucci |
| 5 |
[GO] |
2026―Mrz―11 |
Machine learning-based insight into the evolutionary divergence of spike protein models in SARS-CoV-2 omicron BA.1 and BA.2 sublineages |
Marni E. Cueno, Haruka Tamura, Kenichi Imai |
| 6 |
[GO] |
2026―Feb―12 |
Diosgenin and oleanolic acid interact with the SARS-CoV-2 Envelope protein and modulate viroporin-related cellular phenotypes |
Budhadev Baral, Sayan Poddar, Vaishali Saini, Nidhi Varshney, Ankit Jana, Ajay Kumar Meena, et al. (+2) Parimal Kar, Hem Chandra Jha |
| 7 |
[GO] |
2026―Jan―27 |
In Silico Screening of Phytochemicals from Senna Species Against SARS-CoV-2 Viral and Host Targets: Potential Multi-Target Antiviral Candidates |
Aysha Nawal, Maria Arshad, Tiyyaba Furqan, Syed Tahir Abbas Shah, Ammara Younus, Syed Muhammad Nurulain |
| 8 |
[GO] |
2026―Jan―27 |
Development of a highly specific PrM-based diagnostic marker for dengue virus detection: minimizing cross-reactivity with other flaviviruses and SARS-CoV-2 |
Nisha Yadav, Himani Tripathi, Himesh Dave, Sohail Tanveer, Hemant Arya, Diwakar Kumar, Tarun Kumar Bhatt |
| 9 |
[GO] |
2026―Jan―27 |
In silico assessment of cyanobacterial alkaloids as probable medications against SARS-CoV-2 |
Animesh Sen, Hemantha Mani Kumar Chakravarthi Chanda, Srinivasulu Cheemanapalli, Amineni Umamaheswari, Jnanendra Rath, Nikhilesh Joardar |
| 10 |
[GO] |
2026―Jan―22 |
Design, Synthesis, and In Silico Analysis of Fluorescein-Sorbitol Derivatives as Potential Inhibitors of SARS-CoV and SARS-CoV-2 Proteases |
Mani Rajasekar |
| 11 |
[GO] |
2025―Nov―25 |
In silico analysis of ion channels and lipid metabolism in SARS-CoV-2 infected patients |
John P. George, K. T. Shreya Parthasarathi, Kiran Bharat Gaikwad, Shweta Rana, Vibha Gupta, Punit Kaur, et al. (+3) Akhilesh Pandey, Harpreet Singh, Jyoti Sharma |
| 12 |
[GO] |
2025―Nov―20 |
SHAP-Integrated Machine Learning Framework for Interpretable Survival Modeling in a Synthetic COVID-19 Cohort |
Khalid Ul Islam Rather |
| 13 |
[GO] |
2025―Okt―18 |
Salvia miltiorrhiza derived bioactive compounds inhibit key proteins of SARS-CoV-2: A molecular docking and dynamic simulation study |
Iffat Azam, Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Safdar Ali, Mehboob Hoque |
| 14 |
[GO] |
2025―Okt―15 |
Structure-Based Screening of Antiviral Phytocompounds from the IMPPAT Database Against SARS-CoV-2 Main Protease Using Molecular Docking, MM-GBSA, MD Simulation, and DFT Analysis |
Nikeshun Vivekananthan, Virendra Nath, Chinnakaruppan Marimuthu, Neeraj Kumar, Chandana Venkateshwara Rao, Vijayanandraj Selvaraj |
| 15 |
[GO] |
2025―Okt―04 |
Association Between COVID-19, Diabetes Mellitus Type 1, and Halitosis: A Bioinformatics Approach with Therapeutic Insights from Seaweed Metabolites |
Krishna Kalyan, Dr. Chikoo Cherian |
| 16 |
[GO] |
2025―Sep―25 |
Machine Learning, Bioinformatics and scRNA-seq Analysis of Hub Genes for Co-Diagnosis of COVID-19 and Systemic Lupus Erythematosus |
Kaustav Das, Rajesh Das, Vigneshwar Suriya Prakash Sinnarasan, Dahrii Paul, Md Mujibur Rahman Sheikh, Amouda Venkatesan |
| 17 |
[GO] |
2025―Aug―18 |
In-silico investigation on the discovery of synthesized nucleoside-based antivirals against monkeypox and SARS-CoV-2 Virus |
Thananjeyan Balasubramaniyam, Aparna Ganapathy Vilasam Sreekala, Vinod Kumar Nathan, Kwnag-Im Oh, Jacek Z. Kubiak, Shailima Rampogu |
